In life science research, integration is a powerful force. Even the most promising molecules, in isolation, rarely have much impact. Put the right combination together and something magical happens. Something powerful. Something that transforms human health.

The same is true in real estate. Colliers provides innovative real estate solutions to the life science industry worldwide, through a dedicated group of more than 100 professionals in structured finance and investment sales, development, construction, leasing and facility management. The Group has a major presence in each of the life science clusters and emerging markets in the United States, Canada, Europe and Asia, bringing a truly global understanding of the developments driving the life science industry, a national understanding of the U.S. market and a local perspective as a major player in each local market it serves.

Colliers life science clients include: the National Institutes of Health (NIH), Johns Hopkins University, New York Presbyterian Hospital, The University Hospitals of Columbia and Cornell,  Pfizer, Genzyme, Perkin Elmer, Alta Analytical, The Scripps Research Institute, Biocept and Artes Medical.

Our formula of experience + talent + market research + proprietary technological tools creates exceptional environments that inspire innovation and speed drug development. We have earned a solid reputation for rapid, on-time and under-budget delivery of the most sophisticated life science projects for the world’s leading research centers and largest life science companies.